Suppr超能文献

超越组织浓度:感染部位的抗真菌药物渗透

Beyond tissue concentrations: antifungal penetration at the site of infection.

作者信息

Zhao Yanan, Prideaux Brendan, Baistrocchi Shane, Sheppard Donald C, Perlin David S

机构信息

Public Health Research Institute, New Jersey Medical School-Rutgers Biomedical and Health Sciences, Newark, NJ 07103.

Departments of Medicine, Microbiology & Immunology, McGill University, Montreal, Quebec H4A 3J1.

出版信息

Med Mycol. 2019 Apr 1;57(Supplement_2):S161-S167. doi: 10.1093/mmy/myy067.

Abstract

Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.

摘要

尽管抗真菌治疗取得了进展,但侵袭性真菌感染仍然是全球发病和死亡的重要原因。现有抗真菌药物相对无效的一个重要因素是感染部位的药物暴露不足。尽管这是抗真菌治疗的一个重要方面,但我们通常对抗真菌药物在不同组织亚区室中如何分布、渗透以及与靶标生物体相互作用缺乏全面认识。更好地了解药物分布对于指导当前可用抗真菌药物的合理使用以及辅助新型药物的研发至关重要。在此,我们简要回顾目前关于感染部位抗真菌药物暴露的观点,并描述一种新技术——基质辅助激光解吸电离(MALDI)质谱成像,它有可能极大地扩展我们对药物渗透的理解。

相似文献

1
Beyond tissue concentrations: antifungal penetration at the site of infection.
Med Mycol. 2019 Apr 1;57(Supplement_2):S161-S167. doi: 10.1093/mmy/myy067.
3
Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients.
Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):881-895. doi: 10.1080/17425255.2019.1671971. Epub 2019 Oct 30.
5
Antifungal drugs: An updated review of central nervous system pharmacokinetics.
Mycoses. 2020 Oct;63(10):1047-1059. doi: 10.1111/myc.13157. Epub 2020 Sep 4.
6
Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model.
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01009-17. Print 2017 Oct.
7
Antifungal agents and liver toxicity: a complex interaction.
Expert Rev Anti Infect Ther. 2016 Aug;14(8):765-76. doi: 10.1080/14787210.2016.1199272. Epub 2016 Jun 23.
9
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.
Expert Opin Drug Saf. 2017 Mar;16(3):329-339. doi: 10.1080/14740338.2017.1273900. Epub 2016 Dec 26.
10
Innovative therapies for invasive fungal infections in preclinical and clinical development.
Expert Opin Investig Drugs. 2020 Sep;29(9):961-971. doi: 10.1080/13543784.2020.1791819. Epub 2020 Aug 6.

引用本文的文献

1
Salvage therapy of complicated Candida albicans spondylodiscitis with Rezafungin.
Eur J Clin Microbiol Infect Dis. 2025 Jun;44(6):1523-1526. doi: 10.1007/s10096-025-05117-5. Epub 2025 Mar 31.
4
A Practical Guide to Antifungal Susceptibility Testing.
J Pediatric Infect Dis Soc. 2023 Apr 28;12(4):214-221. doi: 10.1093/jpids/piad014.
5
Diatomaceous earth/zinc oxide micro-composite assisted antibiotics in fungal therapy.
Nano Converg. 2021 Oct 25;8(1):32. doi: 10.1186/s40580-021-00283-6.
6
Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics.
Clin Lab Med. 2021 Jun;41(2):309-324. doi: 10.1016/j.cll.2021.03.009.
8
Therapeutic Challenges of Non- Invasive Mold Infections in Immunosuppressed Patients.
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01244-19. Print 2019 Nov.

本文引用的文献

3
Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model.
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01009-17. Print 2017 Oct.
4
Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00924-17. Print 2017 Sep.
6
Cerebral cryptococcoma mimicking glioblastoma.
BMJ Case Rep. 2017 Feb 10;2017:bcr2016218824. doi: 10.1136/bcr-2016-218824.
8
Blood and tissue distribution of posaconazole in a rat model of invasive pulmonary aspergillosis.
Diagn Microbiol Infect Dis. 2017 Feb;87(2):112-117. doi: 10.1016/j.diagmicrobio.2016.10.010. Epub 2016 Oct 11.
9
Aspergillus in chronic lung disease: Modeling what goes on in the airways.
Med Mycol. 2017 Jan 1;55(1):39-47. doi: 10.1093/mmy/myw117. Epub 2016 Nov 12.
10
Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot.
J Am Soc Mass Spectrom. 2017 Jan;28(1):136-144. doi: 10.1007/s13361-016-1501-2. Epub 2016 Sep 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验